Intermittent claudication in diabetics: Treatment with exercise and pentoxifylline: A 6-month, controlled, randomized trial

Angiology

Volumn 53, Issue SUPPL. 1, 2002, Pages

  Belcaro, G ^a   Nicolaides, A N ^a   Griffin, M ^a   De Sanctis, M T ^a   Cesarone, M R ^a   Incandela, L ^a   Ippolito, E ^a   Pomante, P ^a   Geroulakos, G ^a   Ramaswami, G ^a  

^a PAP/PEA Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; PENTOXIFYLLINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXERCISE TOLERANCE; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIDE EFFECT; WALKING;

AGED; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; EXERCISE TEST; EXERCISE THERAPY; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PENTOXIFYLLINE; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS; WALKING;

EID: 18844477646     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Efficiency of a new prostaglandin E regimen in outpatients with severe intermittent claudication: Results of a multicenter, placebo-controlled double-blind trial
2. Second European Consensus
3. Intermittent claudication: Be conservative
4. A review of the clinical effectiveness of exercise therapy for intermittent claudication
5. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels
6. Value of supervised exercise program for the therapy of arterial claudication
7. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV
8. Changes of walking distance in patients with intermittent claudication during six months intensive physical training
9. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease
10. Planning Clinical trials evaluating treatment in peripheral vascular disease due to atherosclerosis
11. Carotid plaque, intima-media thickness, cardiovascular risk factors and prevalent cardiovascular disease in men and women. The British Regional Heart Study
12. Pentoxifylline (oxpentifylline). A review of its therapeutic efficacy in the management of peripheral vascular and cerebrovascular disease
13. Oxpentifylline treatment of venous ulcers of the leg
14. Oxpentifylline: Effects on red cell deformability and oxygen availability from the blood in intermittent claudication